---
category: news
title: "Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy"
excerpt: "Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene"
publishedDateTime: 2021-01-19T06:05:00Z
originalUrl: "https://www.prnewswire.com/news-releases/neurophth-and-aavnergene-enter-strategic-aav-capsids-partnership-for-next-generation-ophthalmic-gene-therapy-301210596.html"
webUrl: "https://www.prnewswire.com/news-releases/neurophth-and-aavnergene-enter-strategic-aav-capsids-partnership-for-next-generation-ophthalmic-gene-therapy-301210596.html"
type: article
quality: 20
heat: 20
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.prnewswire.com/content/dam/prnewswire/common/prn_facebook_sharing_logo.jpg"
    width: 600
    height: 315
    isCached: true

secured: "eWrSk1/pCdWP/D2huIJOqMFKf604svJO0wbHWhxAj34E4XeJ0+K9wPOqeqRtYjR53v7i7Z/ZDz7xSNAtkVvh7sA9BIW3tcluPmSlak+GppwunjC/28CmJQt1Z3qWZOgdLW7kbCPAMLOWZoTzspVg1WkGY5sZLKWrNIwcAS+9e8/9KAjXZNWp6seBkKMFYRX95CzA3JgR5FDeg4XYfBZyaYVHbxSXsBmq8JEpE6Fuj/Co1JSwVq4RuEL8F4FH050byiDUGsomovYZSXE5x0FD6/rX/h3B4jhJGDSgsnf0+a5yaQTkz0WbB3/QHrEhsNjI07GWWhFhyz78H8btTdaMjwq/n9hjueFYmn00GdeDDOc=;Xl3nV/Nctu5aasrSnKQAJQ=="
---

